Dr. Natalie Mazur, MD MSc is a clinician-investigator at the Wilhelmina Children’s Hospital in Utrecht, the Netherlands. Her research focuses on RSV therapeutics and mucosal antibody transfer following RSV infection. She has recently received awards from the Royal Netherlands Academy of Arts and Sciences (KNAW) as well as the Federation of Clinical Immunology Sciences (FOCIS). She is an active member of the Dutch organization Training Upcoming Leaders in Paediatric Science (TULIPS). Natalie obtained her medical degree from the University of Utrecht after graduating cum laude in biology from Harvard University. She has published in peer-reviewed journals. Natalie’s passion lies not only in advancing paediatric infectious disease but also the implications this research has on global health.